Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Source: SeekingAlpha
2026-03-05 00:42:17 ET
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer March 4, 2026 5:30 PM EST...
Read the full article on Seeking Alpha
For further details see:
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Telix Pharmaceuticals Ltd
NASDAQ: TLPPF
TLPPF Trading
2.92% G/L:
$6.70 Last:
5,100 Volume:
$6.60 Open:
